JCR Pharmaceuticals Co.,Ltd.JP:4552

Market cap

¥163,534m

P/E ratio

41.5

Summary Income statement Balance sheet Cash flow

	Mar 31, 2010	Mar 31, 2011	Mar 31, 2012	Mar 31, 2013	Mar 31, 2014	Mar 31, 2015	Mar 31, 2016	Mar 31, 2017	Mar 31, 2018	Mar 31, 2019	Mar 31, 2020	Mar 31, 2021	Mar 31, 2022	Mar 31, 2023
Net sales	14,387	14,458	12,845	14,100	15,706	16,856	17,438	18,085	20,594	23,160	24,781	30,085	51,082	34,343
Ordinary profit (loss)	1,861	1,312	1,005	1,156	1,681	2,340	2,443	2,534	3,843	5,068	3,293	8,488	20,512	5,418
Profit (loss) attributable to owners of parent
Comprehensive income
Basic earnings (loss) per share
Diluted earnings per share
Net cash provided by (used in) operating activities
Net cash provided by (used in) investing activities
Net cash provided by (used in) financing activities